Lv11
10 积分 2023-09-28 加入
Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease
2小时前
待确认
New perspectives on the origins and heterogeneity of mast cells
4个月前
已完结
Antigen improves binding of IgGs to FcγRs in SPR analysis
4个月前
已完结
For optimal antibody effectiveness, sometimes less is more
5个月前
已完结
Efficacy of dupilumab in palmoplantar pustulosis treatment highlights the role of Th2 inflammation
7个月前
已完结
Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases
9个月前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
10个月前
已完结
Obexelimab in IgG4-related disease: B-cell inhibition as a novel therapeutic approach
1年前
已完结
皖公网安备34019202002308
